Cancer drugs price cap: Will your medicine get cheaper? 10 FAQs on the India's new rule
India has approved a 30% trade-margin cap on non-scheduled cancer medicines, estimating annual savings of ₹2,500 crore for patients. Which drugs could be covered, how much might prices fall, and when will the new rules take effect? Here are 10 FAQs answered.
Read the full report on Cnbctv18
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Cnbctv18
- Reporter
- tenzin norzom
- Published
- Friday, 9 October 2026, 11:26 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Cnbctv18 with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
